BIT 3.23% 3.0¢ biotron limited

$30 Billion Deal, page-58

  1. 1,388 Posts.
    lightbulb Created with Sketch. 284
    I guess my point was, why would BP put a deal on the table if the patent is old.
    It might be substantially cheaper than $30b to finalise development of the drug and tie Biotron up in the courts arguing the patent has expired.
 
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.